-
Weight-loss drug bulks up sales as patients upgrade dosage
The sales grew 60% month on month to Rs 12.60 crore last month from Rs 7.87 crore in April, with the 5 mg injections accounting for Rs 7.53 crore—up 145% from Rs 3.08 crore in the previous month, data from industry tracker PharmaTrac showed. This indicates that patients are upgrading to higher doses after taking an initial base dose of 2.5 mg, experts said.
-
From De Novo Protein Design to Mining ‘Failure’ Data for Future Drugs via AI
-
Novo's Ozempic, Wegovy linked to rare cases of dangerous eye disorder, EMA says
-
UP to hold roadshow in Ahmedabad to boost pharma sector investment
-
Four Democratic-led US states urge FDA to remove abortion pill restrictions
Advertisement
Advertisement
